Core Scientific, Inc Tranche 2 Warrants
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $95,354 | $141,102 | $179,291 | $141,929 |
Gross Profit | -156 | 38,817 | 77,646 | 39,300 |
EBITDA | -419,362 | -758,518 | 254,750 | -80,494 |
EBIT | -448,053 | -789,977 | 224,984 | -111,436 |
Net Income | -455,259 | -804,896 | 210,691 | -195,693 |
Net Change In Cash | 95,354 | 141,102 | 179,291 | 141,929 |
Free Cash Flow | -25,460 | -1,931 | -9,720 | 10,058 |
Cash | 253,019 | 97,105 | 114,276 | 69,709 |
Basic Shares | 292,486 | 178,505 | 282,531 | 385,074 |
Annual Financials
| Values in thousands | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
|---|---|---|---|---|
Revenue | $502,400 | $640,313 | $544,483 | $60,320 |
Gross Profit | 123,459 | 8,400 | 238,862 | 9,392 |
EBITDA | -63,121 | 167,610 | -10 | |
EBIT | -159,566 | 134,248 | -9,413 | |
Net Income | -246,487 | -2,146,318 | 47,312 | -10 |
Net Change In Cash | 502,400 | 640,313 | 544,483 | 60,320 |
Free Cash Flow | 48,953 | -396,470 | -116,010 | -25,333 |
Cash | 50,409 | 15,884 | 131,678 | 8,671 |
Basic Shares | 379,863 | 375,225 | 233,305 | 43,125 |
